Skip to menu Skip to content Skip to footer
Dr Lesley Lluka
Dr

Lesley Lluka

Email: 

Overview

Background

Transporters for Catecholamines and Serotonin. Science Education.

The overall theme of Lesley Lluka's research over 3 decades has been the structure and function of the noradrenaline transporter (NET) and the serotonin transporter (SERT). These transporters are important sites of action of drugs such as antidepressants.

More recently, Lesley Lluka's work has increasingly moved to Science Education, with a focus on areas such as student engagement in practical classes, innovative assessment practices to drive deep learning, and internationalization of the curriculum.

Availability

Dr Lesley Lluka is:
Not available for supervision

Qualifications

  • Bachelor of Pharmacy, The University of Queensland
  • Masters (Coursework), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Internationalisation of the curriculum in biomedical science

  • Role of tutor training in determining student learning outcomes

  • Vertically integrated practical curriculum in physiology

  • Active learning in lectures and 'lectorials'

Works

Search Professor Lesley Lluka’s works on UQ eSpace

90 works between 1991 and 2022

41 - 60 of 90 works

2005

Conference Publication

Quantitative analysis of serotonin levels in the murine brain following treatment with serotonin reuptake inhibitor drugs

Williams, S. M., Bryan-Lluka, L. J. and Pow, D. V. (2005). Quantitative analysis of serotonin levels in the murine brain following treatment with serotonin reuptake inhibitor drugs. 25th Annual Meeting of the Australian Neuroscience Society (ANS), Perth, Australia, 30 January - 2 February 2005. Australia: ANS.

Quantitative analysis of serotonin levels in the murine brain following treatment with serotonin reuptake inhibitor drugs

2005

Conference Publication

Pharmacological and substituded cysteine accessibility method (SCAM) analysis of transmembrane domain 5 (TMD5) of the human noradrenaline transporter

Khamu, T. and Lluka, L. J. (2005). Pharmacological and substituded cysteine accessibility method (SCAM) analysis of transmembrane domain 5 (TMD5) of the human noradrenaline transporter. The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) - Australiasian Pharmaceutical Science Association (APSA) joint Annual Scientific Meeting 2005, Hilton on the Park, Melbourne, Australia, 4-7 December, 2005. Melbourne, Australia: Australian Society of Clinical and Experimental Pharmacologists Pharmacologists and Toxicologists.

Pharmacological and substituded cysteine accessibility method (SCAM) analysis of transmembrane domain 5 (TMD5) of the human noradrenaline transporter

2004

Journal Article

Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT)

Bryan-Lluka, Lesley J., Papacostas, Marisa H., Paczkowski, Filip A. and Wanstall, Janet C. (2004). Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT). British Journal of Pharmacology, 143 (1), 63-70. doi: 10.1038/sj.bjp.0705904

Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT)

2004

Conference Publication

What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?

Sucic, S. and Lluka, L.J. (2004). What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd.

What is the role of transmembrane domain 2 (TMD2) in noradrenaline transporter (NET) function?

2004

Journal Article

Role of proline residues in the expression and function of the human noradrenaline transporter

Paczkowski, FA and Bryan-Lluka, LJ (2004). Role of proline residues in the expression and function of the human noradrenaline transporter. Journal of Neurochemistry, 88 (1), 203-211. doi: 10.1046/j.1471-4159.2003.02149.x

Role of proline residues in the expression and function of the human noradrenaline transporter

2004

Conference Publication

How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?

Paczkowski, F. A., Wanstall, J. C. and Lluka, L.J. (2004). How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?. 8th World Congress on Clinical Pharmacology & Therapeutics, Brisbane, Australia, 1-6 August 2004. Australia: Blackwell Publishing Asia Pty Ltd.

How do nitric oxide donors regulate the function of transporters for serotonin and noradrenaline?

2003

Journal Article

χ-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter

Bryan-Lluka, Lesley J., Bonisch, Heinz and Lewis, Richard J. (2003). χ-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter. Journal of Biological Chemistry, 278 (41), 40324-40329. doi: 10.1074/jbc.M213101200

χ-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter

2003

Journal Article

5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats

Awabdy, Doreen, Bryan-Lluka, Lesley J. and Wanstall, Janet C. (2003). 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats. European Journal of Pharmacology, 459 (1), 1-7. doi: 10.1016/S0014-2999(02)02734-6

5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats

2003

Conference Publication

Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine

Paczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2003). Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine. Summer Meeting of the British Association for Psychopharmacology, Cambridge, England, 20-23 July 2003. Oxford, United Kingdom: Sage Productions.

Evidence for different, but overlapping, binding sites on the human noradrenaline transporter (hNET) for substrates, antidepressants and cocaine

2003

Journal Article

An evaluation of factors affecting computer-based learning in haemostasis: A cultural experience

Overfield, J.A. and Lluka, L.J. (2003). An evaluation of factors affecting computer-based learning in haemostasis: A cultural experience. Bioscience Education E-Journal, 1 (1), 1-9.

An evaluation of factors affecting computer-based learning in haemostasis: A cultural experience

2002

Journal Article

The role of conserved CXXXRXG motif in the expression and function of the human norepinephrine transporter

Sucic, Sonja and Bryan-Lluka, Lesley J. (2002). The role of conserved CXXXRXG motif in the expression and function of the human norepinephrine transporter. Molecular Brain Research, 108 (1-2), 40-50. doi: 10.1016/S0169-328X(02)00512-0

The role of conserved CXXXRXG motif in the expression and function of the human norepinephrine transporter

2002

Journal Article

Functional significance of a highly conserved glutamate residue of the human noradrenaline transportere

Sucic, Sonja, Paczkowski, Filip A., Runkel, Fabian, Bonisch, Heinz and Bryan-Lluka, Leslie J. (2002). Functional significance of a highly conserved glutamate residue of the human noradrenaline transportere. Journal of Neurochemistry, 81 (2), 344-354. doi: 10.1046/j.1471-4159.2002.00826.x

Functional significance of a highly conserved glutamate residue of the human noradrenaline transportere

2002

Journal Article

Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporter

Paczkowski, Filip A., Bonisch, Heinz and Bryan-Lluka, Lesley J. (2002). Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporter. Pharmacogenetics, 12 (2), 165-173. doi: 10.1097/00008571-200203000-00010

Pharmacological properties of the naturally occurring Ala457Pro variant of the human norepinephrine transporter

2002

Journal Article

Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters

Paczkowski, FA and Bryan-Lluka, LJ (2002). Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters. Naunyn-Schmiedeberg's Archives of Pharmacology, 365 (4), 312-317. doi: 10.1007/s00210-002-0528-z

Amino Acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters

2001

Journal Article

Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology

Paczkowski, Filip A. and Bryan-Lluka, Lesley J. (2001). Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology. Molecular Brain Research, 97 (1), 32-42. doi: 10.1016/S0169-328X(01)00295-9

Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology

2001

Journal Article

Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter

Bryan-Lluka, Lesley J., Paczkowski, Filip A. and Bonisch, Heinz (2001). Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter. Neuropharmacology, 40 (4), 607-617. doi: 10.1016/S0028-3908(00)00201-X

Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter

2001

Conference Publication

5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation

Awabdy, D., Bryan-Lluka, L. J. and Wanstall, J. C. (2001). 5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation. ASCEPT Annual Scientific Meeting, University of Otago, Dunedin, New Zealand, 3-5 December, 2001. Victoria, Australia: ASCEPT.

5-hydroxytryptamine and platelet function in hypoxic pulmonary hypertensive rats: Studies on uptake and aggregation

2001

Conference Publication

Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormones

Bryan-Lluka, L. J., Dunner, E. M. and Papacostas, M. H. (2001). Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormones. 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April, 2001. Kyoto, Japan:

Regulation of the norepinephrine transporter (NET) and the serotonin transporter (SERT) by second messengers and hormones

2001

Conference Publication

Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter

Paczkowski, F. A., Sucic, S. and Bryan-Lluka, L. J. (2001). Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter. The 9th International Catecholamine Symposium, Kyoto, Japan/Kyoto International Conference Hall, 31 March - 5 April 2001. Kyoto, Japan: N/A.

Similar effects of mutations in the first intracellular loop and fifth transmembrane domain of the human norepinephrine transporter

2001

Conference Publication

A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .

Bryan-Lluka, L. J., Bonisch, H. and Paczkowski, F. A. (2001). A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .. British Pharmacological Society Meeting, United Kingdom, 5-7 September, 2001. London, England:

A naturally occurring human noradrenaline transporter mutation in transmembrane domain 9 causes differential changes in noradrenaline and cocaine affinities Abstracts of the . .

Funding

Past funding

  • 2013 - 2016
    Development and implementation of MathBench for Australian universities to improve quantitative skills of science and mathematics students (OLT grant administered by Deakin University)
    Deakin University
    Open grant
  • 2009
    Liquid Scintillation Spectroscopy Facility
    UQ School/Centre Co-Funding
    Open grant
  • 2005 - 2007
    Determinants of Expression Assembly and Function of the Noradrenaline Transporter
    ARC Discovery Projects
    Open grant
  • 2003
    To Continue Established Collaboration With Professor Bonisch
    UQ Travel Grants Scheme
    Open grant
  • 2000 - 2002
    Molecular structure-function relationships of the moradrenaline transporter and drug action
    NHMRC Project Grant
    Open grant
  • 1998 - 2000
    Noradrenaline and Serotonin Transporter Regulation Implications for Therapy of Depression
    NHMRC Project Grant
    Open grant
  • 1996 - 1997
    Molecular identification and regulation of expression of monoamine transporters in pulmonary endothelial cells and other cell types - in collaboration with Professor H. Bonisch (Bonn, Germany) and Pro
    Quality Funds Round 3
    Open grant

Supervision

Availability

Dr Lesley Lluka is:
Not available for supervision

Supervision history

Completed supervision

Media

Enquiries

For media enquiries about Dr Lesley Lluka's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au